Biblio

Export 225 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
F. Monacelli, Signori, A., Roffredo, L., Pace, K., Nencioni, A., Pickering, G., Nicolas, M., and Odetti, P., “Algoplus® Scale in Older Patients with Dementia: A Reliable Real-World Pain Assessment Tool.”, J Alzheimers Dis, vol. 56, no. 2, pp. 519-527, 2017.
F. Monacelli, Cea, M., Borghi, R., Odetti, P., and Nencioni, A., “Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1295-1306, 2017.
F. Monacelli, Pizzonia, M., Signori, A., Nencioni, A., Giannotti, C., Minaglia, C., di Casaleto, T. Granello, Podestà, S., Santolini, F., and Odetti, P., “The In-Hospital Length of Stay after Hip Fracture in Octogenarians: Do Delirium and Dementia Shape a New Care Process?”, J Alzheimers Dis, vol. 66, no. 1, pp. 281-288, 2018.
T. B. Monroe, Beach, P. A., Bruehl, S. P., Dietrich, M. S., Rogers, B. P., Gore, J. C., Atalla, S. W., and Cowan, R. L., “The Impact of Alzheimer's Disease on the Resting State Functional Connectivity of Brain Regions Modulating Pain: A Cross Sectional Study.”, J Alzheimers Dis, vol. 57, no. 1, pp. 71-83, 2017.
M. Montero-Odasso, Pieruccini-Faria, F., Bartha, R., Black, S. E., Finger, E., Freedman, M., Greenberg, B., Grimes, D. A., Hegele, R. A., Hudson, C., Kleinstiver, P. W., Lang, A. E., Masellis, M., McLaughlin, P. M., Munoz, D. P., Strother, S., Swartz, R. H., Symons, S., Tartaglia, M. Carmela, Zinman, L., Strong, M. J., and McIlroy, W., “Motor Phenotype in Neurodegenerative Disorders: Gait and Balance Platform Study Design Protocol for the Ontario Neurodegenerative Research Initiative (ONDRI).”, J Alzheimers Dis, vol. 59, no. 2, pp. 707-721, 2017.
A. Montesanto, Crocco, P., Anfossi, M., Smirne, N., Puccio, G., Colao, R., Maletta, R., Passarino, G., Bruni, A. C., and Rose, G., “The Genetic Variability of UCP4 Affects the Individual Susceptibility to Late-Onset Alzheimer's Disease and Modifies the Disease's Risk in APOE-ɛ4 Carriers.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1265-74, 2016.
Y. Moon, Han, S. - H., and Moon, W. - J., “Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.”, J Alzheimers Dis, vol. 51, no. 3, pp. 737-45, 2016.
B. Moon, Kim, S., Park, Y. Ho, Lim, J. - S., Youn, Y. Chul, Kim, S. Y., and Jang, J. - W., “Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1255-1264, 2017.
I. Morales, Cerda-Troncoso, C., Andrade, V., and Maccioni, R. B., “The Natural Product Curcumin as a Potential Coadjuvant in Alzheimer's Treatment.”, J Alzheimers Dis, vol. 60, no. 2, pp. 451-460, 2017.
C. Moran, Beare, R., Phan, T., Starkstein, S., Bruce, D., Romina, M., and Srikanth, V., “Neuroimaging and its Relevance to Understanding Pathways Linking Diabetes and Cognitive Dysfunction.”, J Alzheimers Dis, vol. 59, no. 2, pp. 405-419, 2017.
A. Moreira, Diógenes, M. José, de Mendonça, A., Lunet, N., and Barros, H., “Chocolate Consumption is Associated with a Lower Risk of Cognitive Decline.”, J Alzheimers Dis, vol. 53, no. 1, pp. 85-93, 2016.
P. I. Moreira, “Sweet Mitochondria: A Shortcut to Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1391-1401, 2018.
E. Morenas-Rodriguez, Cervera-Carles, L., Vilaplana, E., Alcolea, D., Carmona-Iragui, M., Dols-Icardo, O., Ribosa-Nogué, R., Muñoz-Llahuna, L., Sala, I., M Sánchez-Saudinós, B., Blesa, R., Clarimón, J., Fortea, J., and Lleo, A., “Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.”, J Alzheimers Dis, vol. 50, no. 2, pp. 539-46, 2016.
E. Morenas-Rodriguez, Sala, I., Subirana, A., Pascual-Goñi, E., Sánchez-Saudinós, M. Belén, Alcolea, D., Illán-Gala, I., Carmona-Iragui, M., Ribosa-Nogué, R., Camacho, V., Blesa, R., Fortea, J., and Lleo, A., “Clinical Subtypes of Dementia with Lewy Bodies Based on the Initial Clinical Presentation.”, J Alzheimers Dis, vol. 64, no. 2, pp. 505-513, 2018.
M. Moreno-Rodriguez, Perez, S. E., Martinez-Gardeazabal, J., Manuel, I., Malek-Ahmadi, M., Rodríguez-Puertas, R., and Mufson, E. J., “Frontal Cortex Lipid Alterations During the Onset of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1515-1532, 2024.
A. R. Morgan, Touchard, S., O'Hagan, C., Sims, R., Majounie, E., Escott-Price, V., Jones, L., Williams, J., and B Morgan, P., “The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 25-36, 2017.
J. - P. Morin, Cerón-Solano, G., Velázquez-Campos, G., Pacheco-López, G., Bermúdez-Rattoni, F., and Díaz-Cintra, S., “Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 69-79, 2016.
E. C. Mormino and Papp, K. V., “Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S633-S646, 2018.
A. V. Morozov, Kulikova, A. A., Astakhova, T. M., Mitkevich, V. A., Burnysheva, K. M., Adzhubei, A. A., Erokhov, P. A., Evgen'ev, M. B., Sharova, N. P., Karpov, V. L., and Makarov, A. A., “Amyloid-β Increases Activity of Proteasomes Capped with 19S and 11S Regulators.”, J Alzheimers Dis, vol. 54, no. 2, pp. 763-76, 2016.
J. C. Morris, Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A., “APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.”, Ann Neurol, vol. 67, no. 1, pp. 122-31, 2010.
A. Morrow, Panyard, D. J., Deming, Y. K., Jonaitis, E., Dong, R., Vasiljevic, E., Betthauser, T. J., Kollmorgen, G., Suridjan, I., Bayfield, A., Van Hulle, C. A., Zetterberg, H., Blennow, K., Carlsson, C. M., Asthana, S., Johnson, S. C., and Engelman, C. D., “Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.”, J Alzheimers Dis, vol. 90, no. 2, pp. 667-680, 2022.
M. E. Mortby, Burns, R., Eramudugolla, R., Ismail, Z., and Anstey, K. J., “Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms.”, J Alzheimers Dis, vol. 59, no. 1, pp. 141-153, 2017.
F. Morys, Potvin, O., Zeighami, Y., Vogel, J., Lamontagne-Caron, R., Duchesne, S., and Dagher, A., “Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study.”, J Alzheimers Dis, vol. 91, no. 3, pp. 1059-1071, 2022.
D. E. Moss, Perez, R. G., and Kobayashi, H., “Cholinesterase Inhibitor Therapy in Alzheimer's Disease: The Limits and Tolerability of Irreversible CNS-Selective Acetylcholinesterase Inhibition in Primates.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1285-1294, 2017.
A. A. Moustafa and Haj, M. El, “Phenomenological Characteristics of Future Thinking in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 4, pp. 1279-1287, 2018.

Pages